Sendero Wealth Management LLC Has $830,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Sendero Wealth Management LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 34.7% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,677 shares of the healthcare conglomerate’s stock after selling 890 shares during the quarter. Sendero Wealth Management LLC’s holdings in UnitedHealth Group were worth $830,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC lifted its holdings in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the period. True Wealth Design LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $31,000. LFA Lugano Financial Advisors SA lifted its holdings in UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares during the period. Finally, Transcendent Capital Group LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $40,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 4.8 %

NYSE UNH opened at $509.58 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock has a 50-day moving average of $498.34 and a 200-day moving average of $502.27. The firm has a market cap of $469.01 billion, a PE ratio of 31.15, a price-to-earnings-growth ratio of 1.41 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.26 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. The ex-dividend date was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is presently 51.34%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on UNH. Robert W. Baird assumed coverage on UnitedHealth Group in a report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price target on the stock. Wells Fargo & Company decreased their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Finally, StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.